David Freyer is an Oncology physician affiliated with University of Southern California. OpenAlex indexes 387 publications with 9,643 citations (h-index 54); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1441 Eastlake Ave
Los Angeles, CA 900896062
Telephone
323-865-3000Provider last certified this registry record 12 Oct 2020.
Clinical trials
- Patient Navigation for Improving Transition Success Among Multiply Disadvantaged Young Adult Survivors of Childhood Cancer
Sponsor: Children's Hospital Los Angeles
- LIFE Cancer Survivorship Database for Pediatric Cancer
Sponsor: Children's Hospital Los Angeles
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
2 NIH research awards on record, funded 2019–2025 per NIH RePORTER. The latest:
- Patient Navigation for Improving Transition Success Among Multiply Disadvantaged Young Adult Survivors of Childhood Cancer
Children'S Hospital of Los Angeles
FY2025$4,236,812R01CA303651 - Project Milestones: Young Adult Cancer Survivorship
University of California-Irvine
FY2024$489,861R01CA237230 - Project Milestones: Young Adult Cancer Survivorship
University of California-Irvine
FY2023$464,540R01CA237230
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Developing national cancer survivorship standards to inform quality of care in the United States using a consensus approach
Journal of Cancer Survivorship
2024 - Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer
Journal of Clinical Oncology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”